Dendreon shares pummeled as Medicare studies coverage – Seattle Times
By admin
|
Dendreon shares pummeled as Medicare studies coverage
Seattle Times Shares of Seattle biotechnology company Dendreon were slammed in after-hours trading Wednesday after Medicare regulators said they were opening an inquiry … BRIEF: Dendreon Down Sharply in the After-Hours (DNDN)Benzinga Dendreon Statement on CMS National Coverage AnalysisPR Newswire (press release) |
June 30th, 2010
This author published 8935 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research